Android Apple

With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors

By Yahoo! Finance   |   4 months ago
With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors

Institutions' significant holdings in Design Therapeutics (NASDAQ:DSGN) indicate control over its share price. Institutional investors, hedge funds, insiders, and private equity firms all play a role in influencing the company's performance and future prospects.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.